The brain has its own immune system, which detects threats and mounts a defense. A growing body of evidence has shown that in ...

Recognizing the signs of mild cognitive impairment meant Di could start treatment earlier to help slow her Alzheimer's ...

Diagnosing Alzheimer’s disease remains a complicated undertaking, in part because several conditions can affect cognition ...

A new study indicates ‘we can identify those that are susceptible to Alzheimer’s disease and give them this peptide [therapy] ...

A widely publicised Cochrane review published on April 16, 2026, set out to synthesise evidence on the efficacy and safety of amyloid β-targeting monoclonal antibodies for Alzheimer's disease.1 The ...

Older adults with anemia had 66% higher odds of developing dementia, with those with elevated Alzheimer’s disease blood ...

A new study​ finds that a simple blood test could predict Alzheimer's disease long before symptoms appear.

STING" molecular switch drives Alzheimer's brain inflammation. Blocking this switch protects synapses in new study.

People have no control over Alzheimer's risk factors such as age, genes and family history. Diet, exercise and adequate sleep ...

Why do memories fade in Alzheimer's disease—and can they be restored? University of California, Irvine researchers have ...

The first interim safety results from a multicenter, safety surveillance study of Alzheimer's disease patients treated with ...

A new class of Alzheimer’s drugs promised to be the first treatments that actually slow the disease rather than just manage ...